Vinylbital
From Wikipedia, the free encyclopedia
|
|
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
| Systematic (IUPAC) name | |
|---|---|
| 5-(1-methylbutyl)-5-vinylpyrimidine-2,4,6(1H,3H,5H)-trione | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | Oral |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | Hepatic |
| Half-life | ? |
| Excretion | Renal |
| Identifiers | |
| CAS number | 2430-49-1 |
| ATC code | N05CA08 |
| PubChem | CID 72135 |
| ChemSpider | 65109 |
| UNII | 3W58ITX06Q |
| KEGG | D07321 |
| Chemical data | |
| Formula | C11H16N2O3 |
| Mol. mass | 224.256 |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Vinylbital, also known as butylvinyl, is a sedative hypnotic drug which is a barbiturate derivative. It was developed by Aktieboleget Pharmacia in the 1950s.[1]
- ^ US Patent 2868790
|
|||||||||||||||||||||||||||||
| This sedative-related article is a stub. You can help Wikipedia by expanding it. |